ENTITY
Hutchmed China Ltd

Hutchmed China Ltd (13 HK)

202
Analysis
Industrials • Hong Kong
HUTCHMED (China) Limited develops, manufactures, and sells pharmaceutical products. The Company offers drugs for oncology and autoimmune diseases treatment. HUTCHMED (China) markets its products worldwide.
more
•07 Dec 2016 09:20

ANIMAL SPIRITS REPORT: APAC Valuation Snapshot (Dec 2016)

Japanese valuations are compelling Emerging markets have re-rated Korea discount intact MSCI China significantly lower valuation than MSCI China...

Share
•07 Dec 2016 08:49

ANIMAL SPIRITS REPORT: APAC Equity Strategy Quarterly Review - Markets, Macro, Themes, and Stocks

Quarterly Review - Macro, Country, Sector, Thematic and Equity Ideas Anticipated the reflationary regime shift, the Fed "hot" policy and the BOJ...

Share
•04 Dec 2016 20:56

The Trump Presidency: A Look from the Inside Out on Possible Impacts in Asian Economies

The author was a senior executive in Trump’s casino organization for 3 years: a view from the inside Trump’s public statements and private...

Logo
343 Views
Share
•22 Nov 2016 01:59

MedTech as an Investment Theme

Medicine is changing. For hundreds of years, the key drivers of progress were biology and chemistry. Now they are data science and software.Big...

Logo
394 Views
Share
x